Lancet

Article	Citations
Donald Bernard Longmore	11372
Interpreting COVID-19 data from China: a call for caution	3055
Human rights considerations are key when choosing a conference location	2999
Establishing equitable partnerships between the Global North and Global South	1860
The acknowledgment of death	1803
Miriam Mutebi: transforming breast cancer care in Africa	1732
Tonsillectomy for recurrent tonsillitis: the NATTINA trial	1731
Does TRIANGLE take down transplantation in mantle cell lymphoma?	1730
Merrill Singer	1526
The injustice of tuberculosis	1426
Atosiban and managing women in preterm labour	1394
Political courage needed to prevent the next pandemic	1264
Hearing intervention and cognitive decline: the ACHIEVE trial	1228
Thinking outside of the tin box	1151
From disappointment to despair: USAID cuts to Myanmar's HIV services	1094
Hypochondria, the ghost at medicine's feast	1062
Department of Error	1028
May Edward Chinn: pioneer of early cancer detection	1011
Ronald Duncan Bradley	984
Israel border closure denying health care to Gazans	920
Considerations for the CHH–Lancet Commission on Health, Conflict, and Forced Displacement	892
Beverly Malone: valuing diversity in nursing	884
Retraction: The first tissue-engineered airway transplantation: 5-year follow-up results	821
On the quantification of military violence in Gaza	819
Mortality during migration through the Darién Gap in Panama in 2018–22	806

Offline: Political declarations—clichés and lies	793
Moderna stalls on African vaccine manufacturing plans	780
Physicians in the digital age	774
End compulsory drug treatment in the Asia-Pacific region	736
Pandemics and the tourism industry: who is in control?	720
Department of Error	692
Moving past the COVID-19 emergency in the USA	692
Calvarium indentations in multiple myeloma and CAR T-cell therapy	689
Nafis Sadik	688
Morphine for Gaza? Limits of care during genocidal violence	683
Interferon shrinks spleen in pregnant patient with myeloproliferative neoplasm	669
“I am disabled, it doesn’t mean I have no dignity”	656
Offline: What have we done to medical students?	639
Prominent skin folds of the scalp provide a superficial clue in acromegaly	636
Department of Error	633
Nigeria: health as a political prerequisite	621
Visa bureaucracy causing GPs to leave the UK	608
A fair day's wage for a fair day's work	600
Offline: Changing the argument for health	596
Anatomy teaching, dissection, and dignity of the dead	589
Department of Error	574
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial	557
Threat level in the Gaza Strip: fatalities per 1000 person-years	547
Imagining alternative paths for WHO 75 years in	546
Remote haemodynamic monitoring in patients with heart failure – Authors' reply	525
Fluid retention and heart failure in the PRECISION trial – Authors' reply	521
Department of Error	519
Department of Error	519
Routine immunisations: reversing the decline	518
Gaining MOMENTUM against anaemic myelofibrosis	518
Human rights and health: a story of justice, hope, and resilience	510
Ophira Ginsburg: educating and empowering women with cancer	502
Lowitja O'Donoghue	495
Associations between parental smoking and teenage alcohol and drug use in the Growing Up in Ireland cohort study: a longitudinal observational study	486
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial – Authors' reply	482
Treatment of vulnerable atherosclerotic plaques: the PREVENT trial	480
Primary health-care practices for deaf children should include early incorporation of a signed language	475
Türkiye rocked by newborn care scandal	470
The 2024 Lasker Awards	470
Pivotal points in the science of dementia risk reduction	469
Offline: The unavoidable reckoning	466
CAR T-cell perspectives in lupus – Authors' reply	459
Delayed immune tolerance through donor haematopoietic stem cell infusion 14 months after kidney transplantation	459
“I'm losing faith in everything”: a qualitative study to understand barriers to accessing suitable mental health support for children and young people in Wales	449
“It's not about us anymore”: after the Le Scouarnec case	445
Colonoscopy versus faecal immunochemical testing in COLONPREV	444
Department of Error	441
Department of Error	440
Jenna Lester: advancing diversity in dermatology	434
Tackling heroin use in Mozambique	430

Lower respiratory tract infections in early childhood	427
A decolonised Commission agenda: the missing ingredients	419
Omicron: fewer adverse outcomes come with new dangers	416
Protecting children from racism: urgent health system actions	416
Health at stake in Kenya elections	410
Implementation of adaptation to climate change in public health in Europe: qualitative thematic analysis	405
The Peer Education Project to improve mental health literacy in secondary school students in England: a qualitative realist evaluation	402
Sackler money to go towards reducing overdose deaths	400
Key questions regarding the SYMPLICITY HTN-3 trial	400
Increasing humanitarian concerns for 2023	393
床前孝子	392
Anna Gilmore: confronting the commercial determinants of health	391
Offline: “I have no place to go”	390
Anthony Bryceson	390
Annabel Sowemimo: countering inequities in health care	387
Immediate versus delayed sequential bilateral cataract surgery	382
US plan to shield science from “inappropriate influence”	379
Orbital atherectomy for stent implantation: the ECLIPSE trial – Authors' reply	370
Perilous two-tier COVID-19 global vaccine roll-out	370
Use the remaining carbon budget wisely for health equity and climate justice	367
The road ahead for immediate kangaroo mother care in resource-constrained health systems	359
How can engagement with political science and international relations for health be improved?	359
Protein provision during critical illness	357
Uniting academies of medicine on climate and health	357
WHO EMRO's initiative on economic sanctions: delayed but promising	356
TRiP(cast) score and thrombosis risk for lower limb immobilisation – Authors' reply	349
Legal accountability for climate change	349
Natural or artificial menstrual cycle for frozen embryo transfer	346
Department of Error	343
South Korean doctors threaten mass resignation	342
To keep health as a unifying force, we must put resources into tackling health misinformation and disinformation	339
Malaria vaccines: a test for global health	337
Politicised threats to science endanger global health and humanity	336
An SMS and animated video intervention to increase uptake of breast cancer screening: a randomised controlled trial	336
Tom Beauchamp	335
A taste of your own medicine: the experience of a transplant	334
Pembrolizumab for locally advanced cervical cancer	334
Iscalimab 600 mg: justified or excessive? – Authors' reply	333
Can the FDA fulfil its mission with a smaller workforce?	332
Efgartigimod for primary immune thrombocytopenia: the ADVANCE IV trial – Authors' reply	329
Efficacy of an adenovirus type 5 vectored SARS-CoV-2 vaccine	325
Treatment of MSSA bacteraemia: a call for a personalised approach	322
Mpox in Kenya	319
The dawn of immunotherapy in mismatch repair proficient colorectal cancer	319
Childhood epilepsy	317
Prioritising maternal health must include care before pregnancy	317
Offline: The death of globalism (part 2)	316
Strikes	313
IMbrave050: the first step towards adjuvant therapy in hepatocellular carcinoma	312
Feasibility of interrupting the transmission of soil-transmitted helminths: the DeWorm3 community cluster-randomised controlled trial in Benin, India, and Malawi	310
High-dose dual-antibiotic loaded bone cement in patients undergoing hemiarthroplasty	309
HPV vaccination and cervical cancer screening	307
Australia to introduce sweeping e-cigarette regulations	297
A just transition for antimicrobial resistance: planning for an equitable and sustainable future with antimicrobial resistance	295
A new drug for rare diseases: pozelimab for CHAPLE disease	294
COVID-19 mRNA vaccination and myocarditis or pericarditis	285
Health and development from preconception to 20 years of age and human capital	285
Long COVID: which symptoms can be attributed to SARS-CoV-2 infection?	284
Population health outcomes in Nigeria compared with other west African countries, 1998–2019: a systematic analysis for the Global Burden of Disease Study	282
Primary health care on the ballot in Australian election	279
Breaking dependency: strengthening the global tuberculosis response in the face of USAID cuts	279
Resurgence of cholera amidst ongoing war in Sudan	279
Nigeria's National Mental Health Act 2021: any challenges ahead?	277
A new era for Africa CDC	276
Indomethacin with or without prophylactic pancreatic stent placement to prevent pancreatitis after ERCP: a randomised non-inferiority trial	274
Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised control	274
Racial inequities in homicide rates: Black women in the USA	274
Preventing cancer: the only way forward	272
Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL)	271
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China	271
The health dimensions of violence in Palestine: a call to prevent genocide	269
Effectiveness and cost-effectiveness of an individualised, progressive walking and education intervention for the prevention of low back pain recurrence in Australia (WalkBack): a randomised controlle	269
Sanctions and the right to health in post-Assad Syria	267
Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED): an open-label, multicentre, randomised controlled trial	266
From innovation to impact in cardiovascular disease	265
Mpox: the need for a coordinated international response	264
Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials	262
Haemophilia	260
Changing gloves and switching instruments to decrease surgical site infection in abdominal surgery	259
Brazil to start widespread dengue vaccinations	257

Efficacy of once-daily, high-dose, oral insulin immunotherapy in children genetically at risk for type 1 diabetes (POInT): a European, randomised, placebo-controlled, primary prevention trial	256
Percutaneous transcatheter valve replacement in individuals with mitral regurgitation unsuitable for surgery or transcatheter edge-to-edge repair: a prospective, multicountry, single-arm trial	256
Realising transformative change in adolescent health and wellbeing: a second Lancet Commission	253
Emergence of vaccine-derived poliovirus in high-income settings in the absence of oral polio vaccine use	252
Visualising facial distortions in prosopometamorphopsia	251
Repeat placental growth factor-based testing in women with suspected preterm pre-eclampsia (PARROT-2): a multicentre, parallel-group, superiority, randomised controlled trial	250
Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study	249
Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial	248
An age of uncertainty: mental health in young people	246
Who pays and what pays off in sexual and reproductive health? A review of the cost and cost-effectiveness of interventions and implications for future funding and markets	246
Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in chronic limb-threatening ischaemia (SWEDEPAD 1): a multicentre, participant-masked, registry-based, random	246
Impact of anti-immigration measures on health	244
Health care under Milei	244
Prademagene zamikeracel for recessive dystrophic epidermolysis bullosa wounds (VIITAL): a two-centre, randomised, open-label, intrapatient-controlled phase 3 trial	242
Knowledge and attitudes towards organ donation among students at An-Najah National University: a cross-sectional study	240
Hypertrophic cardiomyopathy secondary to hydroxychloroquine toxicity in a patient with rheumatoid arthritis	240
Budesonide–formoterol versus salbutamol as reliever therapy in children with mild asthma (CARE): a 52-week, open-label, multicentre, superiority, randomised controlled trial	240
Impact of the COVID-19 pandemic on delayed care of cardiovascular diseases in Europe: a systematic review	239
Efficacy and safety of intravenous nerinetide initiated by paramedics in the field for acute cerebral ischaemia within 3 h of symptom onset (FRONTIER): a phase 2, multicentre, randomised, double-blind	236
Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial	235
Regional action needed to halt antimalarial drug resistance in Africa	235
Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study	233
Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches	233
Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes	232
Measuring the availability of human resources for health and its relationship to universal health coverage for 204 countries and territories from 1990 to 2019: a systematic analysis for the Global Bur	230
Improving children's lives—the case for universality	229
Report of the Lancet Commission on the Value of Death: bringing death back into life	228
The pathogenesis of Parkinson's disease	224
Burden of bacterial antimicrobial resistance in low-income and middle-income countries avertible by existing interventions: an evidence review and modelling analysis	224
Neglected tropical diseases: ending the neglect of populations	223
Shakuntala Thilsted: shifting our approach to food systems	221
Public health and gun violence	220
Traditional Chinese medicine for acute intracerebral haemorrhage	219
On going backwards	219
Co-production of a stakeholder workshop to inform multimorbidity prevention research: working with public contributors to ask the right questions (the MELD-B experience)	219
Assessing adherence to Government's sugar, salt, and calorie reduction targets of the top 20 UK restaurants' menus in 2024: a cross-sectional study	216
Policy and legislative approaches to address the social determinants of violence against children: an umbrella review.	216
Long-term efficacy and public health implications of the Vi-tetanus toxoid conjugate vaccine in Bangladeshi children	215
Warnings over misuse of psychiatry in Russia	214
Irrigation efficacy in CSDH surgery: the FINISH trial – Authors' reply	213
A programme for greater health equity for the next UK Government	213
Mechanical circulatory support for cardiogenic shock	210
Opioids for back and neck pain: the OPAL trial	210
Timing of cardiac surgery and anticoagulants after acute ischaemic stroke	209
Optimal usage of antibacterial sutures for wound closure in clinical trials addressing SSI – Authors' response	208
Unanswered questions from the IRONMAN trial	208
Recommitting to global solidarity: introducing the Kigali Call to Action	206
Racism and the health system	205